Deferred therapy in well and moderately differentiated prostate cancer

Acta Oncol. 1991;30(2):225-6. doi: 10.3109/02841869109092357.

Abstract

One hundred and twenty-two patients with localized prostate cancer were included in a surveillance study. The risk of developing metastases and dying of prostate cancer after 10 years was 20 and 15% respectively. These figures are comparable with results in recent reports on long-term follow-up of after radical prostatectomy and radiation therapy.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Prognosis
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / pathology
  • Prostatic Neoplasms / therapy*
  • Time Factors